Long-Term Response of Classic Kaposi's Sarcoma to Intralesional Doxorubicin: A Case Report

Long-Term Response of Classic Kaposi's Sarcoma to Intralesional Doxorubicin: A Case Report

Classic Kaposi's sarcoma (KS) is a disease with low mortality but high morbidity. The optimum treatment of KS depends upon several factors, including location of lesions, disease progression, severity of symptoms and patient preference. We report the long-term response to the use of intralesion...

Full description

Bibliographic Details
Main Authors: Yasir Azim Mirza, Davide Altamura, Torkan Hirbod, Roberto Verdolini
Format: Article
Language:English
Published: Karger Publishers 2015-02-01
Series:Case Reports in Dermatology
Subjects:
Kaposiߣs sarcoma
Intralesional doxorubicin
Treatment
Classic Kaposiߣs sarcoma
Online Access:http://www.karger.com/Article/FullText/369490
id doaj-df8ec8ce0db14b3bab4d4f45b3c09d4f
record_format Article
spelling doaj-df8ec8ce0db14b3bab4d4f45b3c09d4f2020-11-24T21:42:13ZengKarger PublishersCase Reports in Dermatology1662-65672015-02-0171171910.1159/000369490369490Long-Term Response of Classic Kaposi's Sarcoma to Intralesional Doxorubicin: A Case ReportYasir Azim MirzaDavide AltamuraTorkan HirbodRoberto VerdoliniClassic Kaposi's sarcoma (KS) is a disease with low mortality but high morbidity. The optimum treatment of KS depends upon several factors, including location of lesions, disease progression, severity of symptoms and patient preference. We report the long-term response to the use of intralesional doxorubicin to successfully treat a large cutaneous lesion of KS on a patient refractory to traditional treatments.http://www.karger.com/Article/FullText/369490Kaposiߣs sarcomaIntralesional doxorubicinTreatmentClassic Kaposiߣs sarcoma
collection DOAJ
language English
format Article
sources DOAJ
author Yasir Azim Mirza
Davide Altamura
Torkan Hirbod
Roberto Verdolini
spellingShingle Yasir Azim Mirza
Davide Altamura
Torkan Hirbod
Roberto Verdolini
Long-Term Response of Classic Kaposi's Sarcoma to Intralesional Doxorubicin: A Case Report
Case Reports in Dermatology
Kaposiߣs sarcoma
Intralesional doxorubicin
Treatment
Classic Kaposiߣs sarcoma
author_facet Yasir Azim Mirza
Davide Altamura
Torkan Hirbod
Roberto Verdolini
author_sort Yasir Azim Mirza
title Long-Term Response of Classic Kaposi's Sarcoma to Intralesional Doxorubicin: A Case Report
title_short Long-Term Response of Classic Kaposi's Sarcoma to Intralesional Doxorubicin: A Case Report
title_full Long-Term Response of Classic Kaposi's Sarcoma to Intralesional Doxorubicin: A Case Report
title_fullStr Long-Term Response of Classic Kaposi's Sarcoma to Intralesional Doxorubicin: A Case Report
title_full_unstemmed Long-Term Response of Classic Kaposi's Sarcoma to Intralesional Doxorubicin: A Case Report
title_sort long-term response of classic kaposi's sarcoma to intralesional doxorubicin: a case report
publisher Karger Publishers
series Case Reports in Dermatology
issn 1662-6567
publishDate 2015-02-01
description Classic Kaposi's sarcoma (KS) is a disease with low mortality but high morbidity. The optimum treatment of KS depends upon several factors, including location of lesions, disease progression, severity of symptoms and patient preference. We report the long-term response to the use of intralesional doxorubicin to successfully treat a large cutaneous lesion of KS on a patient refractory to traditional treatments.
topic Kaposiߣs sarcoma
Intralesional doxorubicin
Treatment
Classic Kaposiߣs sarcoma
url http://www.karger.com/Article/FullText/369490
work_keys_str_mv AT yasirazimmirza longtermresponseofclassickaposissarcomatointralesionaldoxorubicinacasereport
AT davidealtamura longtermresponseofclassickaposissarcomatointralesionaldoxorubicinacasereport
AT torkanhirbod longtermresponseofclassickaposissarcomatointralesionaldoxorubicinacasereport
AT robertoverdolini longtermresponseofclassickaposissarcomatointralesionaldoxorubicinacasereport
_version_ 1725918257132601344

Similar Items